-
Budget Impact Model to Evaluate the Inclusion of a Pre-Filled Syringe Compared to Vial Application of Denosumab in Patients with Four Cancer Types in Mexico
Mar 10, 2025, 14:00 PM -
Eosinophilic Esophagitis-Related Healthcare Resource Utilization: A Retrospective Cohort Study of US Health Insurance Claims Data
Mar 10, 2025, 14:00 PM -
The Time Value of Money driven by Early Disease-Modifying Interventions in Degenerative Disease
Mar 10, 2025, 14:00 PM -
Describing the Amyotrophic Lateral Sclerosis US Population and Use of Supportive Aids and Interventions: Results from a Real-World Survey
Mar 10, 2025, 14:00 PM -
Importance of Virtual Access for Mental Health Services: Evidence from ESI Population
Mar 10, 2025, 14:00 PM -
Estimating the Family Spillover Effects of Cardiovascular Diseases: Evidence from the Medical Expenditure Panel Survey
Mar 10, 2025, 14:00 PM -
Factors Responsible for Successful Value-Based Agreements and Barriers for Their Adoption in the United States
Mar 10, 2025, 14:00 PM -
Administrative Frequency of Alopecia Areata and Clinical Characteristics in a Colombian HMO: a Real-World Data Characterization For 2015-2023
Mar 10, 2025, 14:00 PM -
Leveraging CMS Medicare Data for Oncology RWE: Benefits, Limitations, and Opportunities, and Insights into Enrollment Patterns
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Pembrolizumab as Treatment for FIGO 2014 Stage III-IVA Cervical Cancer in the United States
Mar 10, 2025, 14:00 PM -
GenAI for Critical Appraisal of Evidence for Systematic Literature Reviews (SLRs): A Face-Off between GenAI and Human Reviewers
Mar 10, 2025, 14:00 PM -
Unmet Need in Non-Metastatic Oral Cavity Cancer in the United States: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
How Well Does Hospital Billing Data Estimate Readmissions and Revision Risks After Spinal Fusion Surgery, Compared to Hospital Billing Linked to Claims Data?
Mar 10, 2025, 14:00 PM -
The Clinical Impact of Discontinuation of Sodium-Glucose Transport Protein 2 Inhibitors (SGLT2is): A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Socioeconomic Value of Targeted Therapies for HER2+ Breast Cancer in National Reimbursement Drug List of China
Mar 10, 2025, 14:00 PM -
Integrating Patient-Reported Outcomes in Clinical Care: Opportunities and Roadblocks from the Clinician Perspective: A Scoping Review
Mar 10, 2025, 14:00 PM -
Daily Intravenous Ketamine for Treatment-Resistant Depression: a Cost-Effectiveness Analysis Alongside the Clinical Trail
Mar 10, 2025, 14:00 PM -
The Role of Invasive Diagnostics in Prior Authorization for MASH
Mar 10, 2025, 14:00 PM -
Optimizing EHR Data Completeness: A Conceptual Framework for Bringing Real-World Data into Clinical Research through Relevant Completeness
Mar 10, 2025, 14:00 PM -
Analysis and Management of Computable Operational Definition (CODef) Concept Variation Based on a Large Real-World Studies Library
Mar 10, 2025, 14:00 PM
